Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial)
Clinical trial NCT04301375 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04301375
- Sponsor
- David Garcia Cinca
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-15
- Primary completion
- 2027-07-15
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.